文献速递临床试验与 GCP

电针治疗卒中后抑郁的疗效与安全性:随机对照试验研究方案

Efficacy and safety of electroacupuncture for post stroke depression: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-03-02

BACKGROUND: Poststroke depression is closely related to increased mortality in stroke patients. Compared with antidepressants, electroacupuncture (EA) treatment for poststroke depression (PSD) has relatively more stable effectiveness and can reduce side effects.…

要点

  • 电针组取百会、四神聪、肝俞、三阴交、太冲穴,得气并电刺激;假电针组不透皮无电刺激。
  • 主要结局为汉密尔顿抑郁量表评分,在基线、治疗2周、4周及8周随访时评估。

核心结论

  • 该试验旨在为电针治疗卒中后抑郁的疗效与安全性提供可靠的临床证据,支持电针作为卒中后抑郁的理想治疗选择。

关键数值与推荐

  • 电针组接受传统电针治疗并产生得气感,假电针组接受不透皮、无电刺激的假电针治疗。
  • 两组均选取百会、四神聪、肝俞、三阴交、太冲穴,每周治疗3次,共12次,持续4周。
  • 主要结局为汉密尔顿抑郁量表评分,次要结局包括Zung抑郁自评量表、美国国立卫生研究院卒中量表、Barthel日常生活活动指数及中医抑郁量表评分。
  • 所有结局指标在基线、电针治疗开始后2周、4周及8周随访时评估,安全性评估在每次访视时进行。

临床怎么用

  • 若试验结果阳性,电针可能成为卒中后抑郁的一种安全性较好且疗效稳定的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poststroke depression is closely related to increased mortality in stroke patients. Compared with antidepressants, electroacupuncture (EA) treatment for poststroke depression (PSD) has relatively more stable effectiveness and can reduce side effects. This trial is designed to provide solid evidence for the efficacy and safety of EA treatment for patients with PSD. METHODS/DESIGN: This ongoing study is a single-blind, single-center, parallel group, randomized controlled trial. Sixty-two participants will be recruited from Shanghai Shuguang Hospital and randomized into either the EA group or the sham EA group. Baihui, Sishencong, Ganshu, Sanyinjiao, and Taichong are selected as the treatment acupoints in both groups. The EA group will receive the traditional EA treatment with de-qi sensation, and the sham EA group will receive sham EA treatment without needle penetration and electrostimulation. Participants will receive treatment 3 times per week for a total of 12 sessions over 4 weeks. The primary outcome is Hamilton Rating Scale for Depression score, and the secondary outcomes are scores on the Zung Self-Rating Depression Scale, National Institutes of Health Stroke Scale, Barthel Index of Activities of Daily Living, and Depression Scale of traditional Chinese medicine. All of the outcome measures will be assessed at baseline, 2 weeks after EA treatment onset, 4 weeks after treatment onset, and at 8-week follow-up. Safety assessments will be done at each visit. DISCUSSION: The results of this trial will demonstrate the efficacy and safety of EA treatment for PSD with credible and important clinical evidence, thus supporting EA treatment as an ideal choice for PSD treatment. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-IOR-17012610. Registered on 7 September 2017. http://www.chictr.org.cn/edit.aspx?pid=21494&htm=4.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Cai W, Ma W, Wang GT, et al. Efficacy and safety of electroacupuncture for post stroke depression: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29499745. doi:10.1186/s13063-018-2548-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。